| |
|
Asia Global Research Co., Ltd.
33 Sukhumvit 3, Bangkok 10110,Thailand |
|
|
|
AGR announces collaboration with a European company
Bangkok, Thailand (May 13, 2010) - Asia Global Research Ltd. (AGR), a leading clinical research organization (CRO) in Asia is pleased to announce our collaboration with a European-based biotech company to conduct a phase III clinical trial in oncology. The investigational drug is a novel tyrosine kinase inhibitor.
James Mash, AGR’s CEO, stated “This new partnership is an exciting collaboration for us. The investigational product is one of a promising molecule for the treatment of various cancers and inflammatory diseases. Our current capabilities certainly serve the sponsor’s stringent requirements with unrivaled services.”
About AGR:
AGR is a subsidiary of Bumrungrad Hospital Public Company Limited (SET:BH), based in Bangkok, Thailand. Through its CRO and SMO business segments, the Company offers a broad range of Phase I to IV clinical trials, BE study and staffing. AGR’s trial management capabilities include establishing and monitoring trials in Thailand, Vietnam, Malaysia, the Philippines, China, India and the Middle East. Further information is available at www.agr-cro.com or email info@agr-cro.com |
For More Information
Email :info@agr-cro.com
|
|
|
|
